NCT06982846View on ClinicalTrials.gov

A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

PHASE1RecruitingINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Retatrutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

8010

RECRUITING

Medizinische Universität Graz, Graz

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY